First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome

NCT01651637 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Distress Syndrome in Premature Infants

Interventions

DRUG: synthetic surfactant (CHF5633)

Sponsor

Chiesi Farmaceutici S.p.A.